Marco Gattorno

Active 2001–2025

179
Papers
23,172
Citations
86
h-index
170
i10-index

Citations

Citations per year for Marco Gattorno1964: 1 citations1990: 1 citations1997: 1 citations2000: 4 citations2003: 2 citations2005: 7 citations2006: 26 citations2007: 53 citations2008: 131 citations2009: 170 citations2010: 148 citations2011: 167 citations2012: 169 citations2013: 173 citations2014: 172 citations2015: 194 citations2016: 190 citations2017: 213 citations2018: 176 citations2019: 859 citations2020: 1,133 citations2021: 1,064 citations2022: 874 citations2023: 603 citations2024: 970 citations2025: 445 citations2026: 11 citations1965–1989: no citations, so these years are not shown1991–1996: no citations, so these years are not shown1998–1999: no citations, so these years are not shown2001–2002: no citations, so these years are not shown2004: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,049 citing papers, 20.2% of this breakdownChina: 870 citing papers, 8.6% of this breakdownItaly: 853 citing papers, 8.4% of this breakdownUnited Kingdom: 649 citing papers, 6.4% of this breakdownGermany: 607 citing papers, 6% of this breakdownFrance: 481 citing papers, 4.7% of this breakdownNetherlands: 339 citing papers, 3.3% of this breakdownCanada: 303 citing papers, 3% of this breakdownSwitzerland: 271 citing papers, 2.7% of this breakdownTürkiye: 269 citing papers, 2.6% of this breakdownSpain: 240 citing papers, 2.4% of this breakdownJapan: 229 citing papers, 2.3% of this breakdown
0%20.2%Other 29.4%

Fields

  • Medicine40.7%
  • Immunology and Microbiology29.1%
  • Biochemistry, Genetics and Molecular Biology27.1%
  • Neuroscience1.2%
  • Nursing0.3%
  • Agricultural and Biological Sciences0.3%
  • Other1.3%

Topics

  • Inflammasome and immune disorders9.6%
  • Immune Cell Function and Interaction4.4%
  • T-cell and B-cell Immunology3.8%
  • Autoimmune and Inflammatory Disorders Research3.7%
  • interferon and immune responses2.6%
  • Immunodeficiency and Autoimmune Disorders2.6%
  • Other73.3%

Coauthors

All papers

Open in search
  1. OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 cited by 559

  2. Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β

    Authors: , , , , , , , , - Nature 2012 cited by 930

  3. Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence

    Authors: , , , , , , , , , , , , , , , , , , - JAMA 2016 cited by 381

  4. Classification criteria for autoinflammatory recurrent fevers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ricardo Russo, Yael Shinar, Anna Simon, Nataša Toplak, Isabelle Touitou, Yosef Uziel, Mariëlle van Gijn, Dirk Foell, Claudia Garassino, Dan Kastner, Alberto Martini, Maria Pia Sormani, Nicolino Ruperto - Annals of the Rheumatic Diseases 2019 cited by 561

  5. EULAR recommendations for the management of familial Mediterranean fever

    Authors: , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2016 cited by 595

  6. Regulation of Human Macrophage M1–M2 Polarization Balance by Hypoxia and the Triggering Receptor Expressed on Myeloid Cells-1

    Authors: , , , , , , , , , - Frontiers in Immunology 2017 cited by 278

  7. Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , C. Thumerelle, Eline van Aerde, Stefano Volpi, Sophie Willcocks, Carine Wouters, Sylvain Breton, Thierry Jo Molina, Brigitte Bader‐Meunier, Despina Moshous, Alain Fischer, Stéphane Blanche, Frédéric Rieux‐Laucat, Yanick J. Crow, Bénédicte Neven - The Journal of Allergy and Clinical Immunology In Practice 2020 cited by 207

  8. Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells

    Authors: , , , , , , , - Nature Immunology 2007 cited by 1,808

  9. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 473

  10. Deficiency in coatomer complex I causes aberrant activation of STING signalling

    Authors: , , , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 96

  11. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian Ferguson, Polly J. Ferguson, Laura S. Finn, Marco Gattorno, Alexei A. Grom, Eric P. Hanson, Philip J. Hashkes, Christian M. Hedrich, Ronit Herzog, Gerd Horneff, Rita Jerath, Elizabeth A. Kessler, Hanna Kim, D. Kingsbury, Ronald M. Laxer, Pui Y. Lee, Min Ae Lee‐Kirsch, Laura B. Lewandowski, Suzanne C. Li, Vibke Lilleby, Vafa Mammadova, Lakshmi N. Moorthy, Gulnara Nasrullayeva, Kathleen M. O’Neil, Karen Onel, Seza Özen, Nancy Pan, Pascal Pillet, Daniela Gerent Petry Piotto, Marilynn Punaro, Andreas Reiff, Adam Reinhardt, Lisa G. Rider, Rafael Rivas‐Chacon, Tova Ronis, Angela Rösen‐Wolff, Johannes Roth, Natasha M. Ruth, Marite Rygg, Heinrike Schmeling, Grant S. Schulert, Christiaan Scott, Gisella Seminario, Andrew Shulman, Vidya Sivaraman, Mary Beth F. Son, Yuriy Stepanovskiy, Elizabeth Stringer, Sara Mansfield Taber, Maria Teresa Terreri, Cynthia J. Tifft, Troy R. Torgerson, Laura L. Tosi, Annet van Royen‐Kerkhof, Theresa Wampler Muskardin, Scott Canna, Raphaela Goldbach‐Mansky - Journal of Clinical Investigation 2019 cited by 239

  12. ARF1 prevents aberrant type I interferon induction by regulating STING activation and recycling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 49

  13. Type I interferon-mediated autoinflammation due to DNase II deficiency

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Flavio Faletra, M Girard, Annie Harroche, Evelyn Hartmann, Dominique Lasne, Annalisa Marcuzzi, Bénédicte Neven, Patrick Nitschké, Tiffany Pascreau, Serena Pastore, Capucine Pïcard, Paolo Picco, Elisa Piscianz, Michel Polak, Pierre Quartier, Marion Rabant, Gabriele Stocco, Andrea Taddio, Florence Uettwiller, Erica Valencic, Diego Vozzi, Gunther Hartmann, Winfried Barchet, Olivier Hermine, Brigitte Bader‐Meunier, Alberto Tommasini, Yanick J. Crow - Nature Communications 2017 cited by 228

  14. Neutrophil Extracellular Traps-DNase Balance and Autoimmunity

    Authors: , , , , , , , , , , - Cells 2021 cited by 58

  15. Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2017 cited by 135

  16. An Update on Familial Mediterranean Fever

    Authors: , , , , , , , , - International Journal of Molecular Sciences 2023 cited by 131

  17. Anti-interleukin-1 agents for pericarditis: a primer for cardiologists

    Authors: , , , , , , - European Heart Journal 2021 cited by 75

  18. Interface Gain-of-Function Mutations in TLR7 Cause Systemic and Neuro-inflammatory Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Immunology 2024 cited by 44

  19. On the Alert for Cytokine Storm: Immunopathology in COVID‐19

    Authors: , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2020 cited by 657

  20. Consensus classification criteria for paediatric Behçet's disease from a prospective observational cohort: PEDBD

    Authors: , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2015 cited by 244

  21. The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Lara D. Veeken 2018 cited by 204

  22. Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2017 cited by 204

  23. The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul Brogan, Raphaela Goldbach‐Mansky - Annals of the Rheumatic Diseases 2022 cited by 91

  24. Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study

    Authors: , , , , , , - Annals of the Rheumatic Diseases 2018 cited by 185